Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles MacHell

Clinical Cardiac Electrophysiology San Antonio, TX Medical Doctor

NPI 1245230507 CMS profile 282971

6800 Ih 10 W, Ste 350, San Antonio, TX 78201

Open in the dashboard

General payments

$4,461

165 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$31,208 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Charles MacHell of San Antonio, TX is reported in the CMS Open Payments database as having received $4,461 across 165 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $31,208 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 20th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $274 7
2024 General $316 11
2023 General $526 10
2022 General $405 20
2021 General $520 31
2020 General $824 35
2019 General $1,595 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles MacHell
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Charles MacHell were reported at $274. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Charles MacHell Clinical Cardiac Electrophysiology median Middle half National median
2019 $1,595 $2,361 $585–$8,260 $163
2020 $824 $993 $247–$4,351 $114
2021 $520 $1,185 $326–$4,739 $132
2022 $405 $2,073 $554–$6,789 $149
2023 $526 $2,568 $759–$8,159 $160
2024 $316 $2,557 $703–$7,403 $164
2025 $274 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Respicardia, Inc. $912 3 payments
  2. Medtronic, Inc. $789 45 payments
  3. Medtronic Vascular, Inc. $743 58 payments
  4. Boston Scientific Corporation $723 18 payments
  5. Biotronik Inc. $396 9 payments
  6. Biosense Webster, Inc. $346 11 payments
  7. Abbott Laboratories $306 7 payments
  8. Novartis Pharmaceuticals Corporation $60 3 payments
  9. W. L. Gore & Associates, Inc. $48 3 payments
  10. Janssen Pharmaceuticals, Inc $44 2 payments
  11. Other $93 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,653 162 payments
  2. Travel and Lodging $779 2 payments
  3. Education $29 1 payment
Products named General payments · program years 2019–2025
  1. remede System $912 3 payments
  2. Accent Pacemaker $210 2 payments
  3. AZURE XT DR MRI SURESCAN $210 15 payments
  4. Carto 3 $197 4 payments
  5. Micra $183 9 payments
  6. Rivacor $180 4 payments
  7. Solia $180 4 payments
  8. Edora $180 4 payments
  9. BioMonitor $180 4 payments
  10. Acticor $180 4 payments
  11. Other $2,340 125 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

304

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$62,810

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

39.1%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 73 $57,267
Flecainide Acetate Generic 80 $3,586
Sotalol Sotalol Hcl Brand 46 $663
Amiodarone Hcl Generic 34 $544
Metoprolol Succinate Generic 27 $406
Metoprolol Tartrate Generic 25 $217
Carvedilol Generic 19 $126

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$85,778

Medicare's payments for the services billed

Medicare patients

344

Average age 76

Services billed

1,275

152 women, 192 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 60%
Ischemic heart disease 53%
Heart failure 50%
Arthritis 48%
Diabetes 38%
Chronic kidney disease 35%
COPD 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

165 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record